Moreover, the neuroinflammatory and neurodegenerative effects of the cGAS‐STING pathway may not be limited to PD, as evidenced by cGAS‐STING activation in other neurodegenerative diseases such as Huntington's disease, Niemann–Pick disease type C, ALS, and AD.18, 52, 53, 54. This evidence concerns the gene STING1 and amyotrophic lateral sclerosis.